Live Events

 
Live event schedule coming soon. Questions about upcoming live events can be sent to live@PeerView.com.
November
13
Wednesday
7:00 PM

Atopic Dermatitis

A Closer Look at the Atopic Dermatitis Patient Journey: Effective Management Approaches Across the Age and Disease Spectrum

Ruchi S. Gupta, MD, MPH
Northwestern University Feinberg School of Medicine
Ann & Robert H. Lurie Children’s Hospital of Chicago
Center for Food Allergy & Asthma Research (CFAAR)
Chicago, Illinois

Robert Sidbury, MD, MPH
Seattle Children's Hospital
University of Washington School of Medicine
Seattle, Washington

January
27
Mon
2:00 PM
January
28
Tue
4:30 PM
7:00 PM

Eosinophilic Granulomatosis With Polyangiitis

Overcoming Challenges Associated With the Diagnosis and Management of EGPA: An Exploration of Novel Approaches

Praveen Akuthota, MD
University of California San Diego
La Jolla, California

June
10
Wednesday
7:00 PM

Immuno-Oncology

Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team

Brendon Stiles, MD
Associate Professor, Department of Cardiothoracic Surgery
Weill Cornell Medicine/NewYork-Presbyterian Hospital
New York, New York

June
11
Thursday
08:00 CEST

Leukemia

Transforming Care With BTK Inhibitors in CLL: New Insights on Therapy Selection, Safety, and Sequencing Across the Treatment Continuum

Professor Florence Cymbalista, MD, PhD
Hopital Avicenne, AP-HP
University of Paris 13
Bobigny, France

June
16
Tuesday
18:00 CEST

Leukemia

Transforming Care With BTK Inhibitors in CLL: New Insights on Therapy Selection, Safety, and Sequencing Across the Treatment Continuum

Professor Florence Cymbalista, MD, PhD
Hopital Avicenne, AP-HP
University of Paris 13
Bobigny, France

June
17
Wednesday
7:00 PM

Venous Thromboembolism (VTE)

Teaming Up to Reduce the Burden of Cancer-Associated VTE: Applying the Latest Guidelines and Evidence in Gastrointestinal and Hematologic Malignancies and Other Cancer Settings

Alok A. Khorana, MD, FACP, FASCO
Taussig Cancer Institute
Cleveland Clinic Lerner School of Medicine Case Western Reserve University
Cleveland Clinic
Cleveland, Ohio

June
22
Monday
7:00 PM

Gastric Cancer

Up Close and Personalizing Gastric Cancer Care: Precision Medicine With HER2-Targeted Therapies and Other Novel Agents

David H. Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, New York

June
22
Monday
6:30 PM
June
30
Tuesday
12:00 PM

Lymphoma

BTK Inhibitors as a Centerpiece of Care for Hematologic Cancers

John C. Byrd, MD
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

June
13
Saturday
6:15 PM
June
23
Tuesday
12:00 PM
June
24
Wednesday
7:00 PM
June
25
Thursday
12:00 PM

Endocrinology, Cardiology, and Nephrology

Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases

John B. Buse, MD, PhD
NC Translational and Clinical Sciences Institute
University of North Carolina School of Medicine
Chapel Hill, North Carolina

June
23
Tuesday
7:00 PM

Prostate Cancer

How I Think, How I Treat: Learning to Navigate the Modern Prostate Cancer Landscape

William K. Oh, MD
Icahn School of Medicine at Mount Sinai
The Tisch Cancer Institute
New York, New York

June
23
Tuesday
6:30 PM
July
1
Wednesday
12:00 PM
June
24
Wednesday
7:00 PM

Leukemia

Transforming Modern Care in AML: Clinical Solutions With Novel Agents for Diverse Patient Populations

Harry P. Erba, MD, PhD
Duke University Medical Center
Durham, North Carolina

June
25
Thursday
7:00 PM

Lung Cancer

Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer

Suresh S. Ramalingam, MD, FACP, FASCO
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

June
29
Monday
7:00 PM

Myelofibrosis

Following the Evidence to Effective Therapy for Myelofibrosis: How Clinicians Can Overcome Challenges in Patient Care in the JAK Inhibitor Era

Ruben A. Mesa, MD, FACP
Mays Cancer Center at UT Health San Antonio MD Anderson
San Antonio, Texas

June
30
Tuesday
7:00 PM

Oncology

Patient Stories From the HCC CaseBook: Expert Guidance on Optimizing Outcomes and Care With Newly Available and Emerging Therapies

Richard S. Finn, MD
David Geffen School of Medicine at UCLA
Los Angeles, California

July
1
Wednesday
7:00 PM

Oncology

How I Think, How I Treat: Understanding Innovation in Multiple Myeloma—New Models for Attacking Disease Across the Clinical Spectrum

Sagar Lonial, MD, FACP
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

July
2
Thursday
11:00 AM

Gastric Cancer

Optimizing Precision Medicine in Gastric Cancer Care: Essential Guidance on Translating Scientific Advances With Novel HER2-Targeted Therapies and Other Agents Into Current Clinical Practice

Josep Tabernero, MD, PhD
Vall d’Hebron University Hospital (HUVH)
Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain

July
2
Thursday
7:00 PM

Gynecologic Cancers

Practical Perspectives on Rapid Change in Endometrial and Cervical Cancer Management: Exploring Innovative Therapy in Gynecologic Malignancies

Linda R. Duska, MD, MPH
University of Virginia School of Medicine
Charlottesville, Virginia

July
7
Tuesday
7:00 PM

Ovarian Cancer

Optimizing Precision Medicine in Ovarian Cancer: Expert Insights on Clinical Implications of PARP Inhibitor Therapy and Companion Diagnostics

Bradley J. Monk, MD, FACS, FACOG
Arizona Oncology (US Oncology Network)
University of Arizona College of Medicine
Creighton University School of Medicine at St. Joseph’s Hospital
US Oncology Research Network
Phoenix, Arizona

July
8
Wednesday
7:00 PM
July
9
Thursday
7:00 PM

Bladder Cancer

Evidence and Insights on Innovative Treatment for Bladder Cancer: Clinical Breakthroughs From Targeted and Immune Options to Antibodies and Gene Therapy

Arjun Balar, MD
Laura and Isaac Perlmutter Cancer Center
NYU Langone Health
New York, New York

July
16
Thursday
7:00 PM

Interstitial Lung Diseases (ILDs)

Differential Diagnosis of Interstitial Lung Diseases: Interpreting HRCT Accurately and Working With a Multidisciplinary Approach

Jonathan H. Chung, MD
The University of Chicago Medicine
Chicago, Illinois

Steven D. Nathan, MD
Inova Fairfax Hospital
Virginia Commonwealth University-Inova Fairfax Campus
Falls Church, Virginia

July
24
Friday
1:30 PM

Pulmonology

How I Think, How I Treat: Contemporary Insights on Diagnosing and Managing SSc-ILD in an Evolving Treatment Landscape

Lisa H. Lancaster, MD
Vanderbilt University Medical Center
Nashville, Tennessee

August
11
Tuesday
7:00 PM

Lymphoma

Perspectives on Innovative Treatment for B-Cell Malignancies: The Convergence of Precision Medicine With Groundbreaking Therapeutics

John M. Pagel, MD, PhD
Center for Blood Disorders and Stem Cell Transplantation
Swedish Cancer Institute
Seattle, Washington

August
13
Thursday
7:00 PM

Breast Cancer

The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage and Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons

George Plitas, MD
Weill Cornell Medical College
Memorial Sloan Kettering Cancer Center
New York, New York

August
17
Monday
8:00 PM EDT
September
2
Wednesday
7:00 PM EDT
August
18
Tuesday
8:00 PM EDT
September
1
Tuesday
7:00 PM EDT
August
31
Monday
16:30 CEST
September
15
Tuesday
18:00 CEST

Leukemia

Antibody Therapy in Acute Leukemia: Understanding Clinical Considerations for Use in Conjunction With HSCT

Professor David I. Marks
University Bristol NHS Foundation Trust
Bristol, United Kingdom

September
2
Wednesday
4:45 PM
September
10
Thursday
7:00 PM

Neurofibromatosis

Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach

Concetta (Connie) DiDomenico, RN, MSN, PNP-BC, CPHON
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania

Michael J. Fisher, MD
The Children's Hospital of Philadelphia
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania

September
9
Wednesday
6:00 PM CDT
October
14
Wednesday
4:14 PM CDT
October
20
Tuesday
7:00 PM EDT

Cancer Immunotherapies/Biomarkers

Navigating the Complexities of Biomarker Testing in the Expanding Field of Precision Immuno-Oncology: Latest Evidence, Current Challenges, and Practical Guidance for Pathologists

Kurt Schalper, MD, PhD
Assistant Professor of Pathology and Medicine
Yale School of Medicine
Director Translational Immuno-oncology Laboratory
Yale Cancer Center
New Haven, Connecticut

September
10
Thursday
8:45 AM CDT
October
13
Tuesday
5:45 PM CDT
October
21
Wednesday
7:00 PM EDT

Leukemia

The Pathology–Oncology Partnership in AML: Identifying and Treating the Diversity of Disease Subtypes

Naval Daver, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Joseph D. Khoury, MD, FCAP
The University of Texas
MD Anderson Cancer Center
Houston, Texas

September
11
Friday
6:30 AM

Chronic Lymphocytic Leukemia

Achieving Innovation in CLL Care With BTK Inhibitors: Selection, Safety, and Sequencing Across the Disease Continuum

William G. Wierda, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Philip A. Thompson, MB, MS
The University of Texas
MD Anderson Cancer Center
Houston, Texas

September
11
Friday
2:30 PM EDT

Multiple sclerosis

What’s New in Relapsing MS? Expert Perspectives on Pathogenesis, Targeting B Cells for Treatment, and Advances in Disease-State Monitoring

Prof. Xavier Montalban
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron Barcelona Hospital Campus
Barcelona, Spain

September
11
Friday
5:56 PM

Multiple Myeloma

The Rise of Novel Antibodies in Multiple Myeloma: Exploring the Present and Future of Antibody-Based Treatment From CD38 to BCMA

Sagar Lonial, MD, FACP
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Robert Z. Orlowski, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

September
15
Tuesday
7:00 PM

Chronic Kidney Disease

Evolving Management Approaches to Anemia in Chronic Kidney Disease: Implications for the Nephrology Nurse

Jay B. Wish, MD
Indiana University Health
Indianapolis, Indiana

September
17
Thursday
9:00 AM

Solid Tumors

The Oncology Nursing Guide to Tumor Treating Fields as a Fourth Modality in Cancer Treatment: Understanding the Science and Evidence and Implementing Critical Nursing Roles in Practice

Suriya Jeyapalan, MD, MPH
Tufts Medical Center
Boston, Massachusetts

Madeline Couch, MSN, FNP-C
Tufts Medical Center
Boston, Massachusetts

September
30
Wednesday
7:00 PM EDT
October
28
Wednesday
7:00 PM Chinese Standard Time (CST)
November
18
Wednesday
7:00 PM AEDT

Tenosynovial Giant Cell Tumors (TGCT)

Solutions for Tenosynovial Giant Cell Tumors: Employing Effective Multimodal and Multidisciplinary Approaches to Patient Care

Robin L. Jones, MD
Royal Marsden Hospital and Institute of Cancer Research
London, England, United Kingdom

October
5
Monday
7:00 PM EDT

Renal Cell Carcinoma

At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents

Toni K. Choueiri, MD
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

October
20
Tuesday
8:00 AM PDT
October
27
Tuesday
7:00 PM EDT

Neurofibromatosis

Progressive Pathways: Recent Recommendations and Emerging Therapies for Treating NF1 Associated Tumors

Roger J. Packer, MD
Gilbert Family Neurofibromatosis Institute
Brain Tumor Institute
Children’s National Hospital
The George Washington University Medical Center
Washington, DC

October
22
Thursday
9:00 AM EDT
October
28
Wednesday
12:00 PM EDT

Epilepsy

Cannabidiol in the Treatment Arsenal for Severe Epilepsy Syndromes: Practical Guidance for Managed Care Professionals

Orrin Devinsky, MD
NYU Epilepsy Center
NYU Grossman School of Medicine
New York, New York

Sheldon J. Rich, RPh, PhD
SJR Associates, LLC
University of Michigan
Sarasota, Florida

October
27
Tuesday
5:30 PM EDT
November
10
Tuesday
7:00 PM EST
December
4
Friday
7:00 AM PST

Acute Lymphoblastic Leukemia

Exploring Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management

Professor David I. Marks, MB, MS, FRACP, PhD, FRCPath
University Bristol NHS Foundation Trust
Bristol, United Kingdom

December
4
Friday
7:00 AM PST

Chronic Lymphocytic Leukemia

Mapping the New Era in CLL Management: Precision Medicine, Optimized Therapeutic Sequencing, and Patient Perspectives in Treatment-Naïve and Relapsed Disease

John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci
Barts Cancer Institute
Barts and The London School of Medicine, Queen Mary, University of London
London, England, United Kingdom

December
4
Friday
7:00 AM PST

Acute Myeloid Leukemia

How I Think, How I Treat in the New Age of AML Care: Personal Perspectives on New Evidence and Innovative Therapeutics

Naval Daver, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Harry P. Erba, MD, PhD
Duke University Medical Center
Durham, North Carolina

Live event schedule coming soon. Questions about upcoming live events can be sent to live@PeerView.com.
September
11
Wednesday
11:00 AM

Immuno-Oncology Biomarkers

A Pan-Cancer, Pan-Biomarker Exploration of the Opportunities to Realize the Potential of Precision Immuno-Oncology: Are Pathology Professionals Ready for the Challenge?

Phoenix, Arizona

Kurt Schalper, MD, PhD
Yale School of Medicine
Yale Cancer Center
New Haven, Connecticut

September
13
Friday
11:00 AM

Leukemia

Pathology Insights on Innovation in AML: The Rapid Emergence of Precision Diagnostics & Novel Therapy Across the Spectrum of Care

Phoenix, Arizona

Carlos E. Bueso-Ramos, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Naval Daver, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

September
16
Monday
5:45 PM

NSCLC

NSCLC Tumor Board: Navigating the Evolving Role of Immunotherapy in Multimodal Management of Locally Advanced and Early-Stage Lung Cancer

Chicago, Illinois

Roy H. Decker, MD, PhD
Professor & Vice Chair
Director of Clinical Research
Department of Therapeutic Radiology
Yale School of Medicine
New Haven, Connecticut

September
16
Monday
5:45 PM

Solid Tumors

Readying the Modern Radiation Oncology Practice for Incorporation of a Fourth Modality in Cancer Treatment: Understanding the Science, Evidence, & Clinical Application Across a Range of Solid Malignancies

Chicago, Illinois

Matthew T. Ballo, MD, FACR
Professor and Chair of Radiation Oncology
West Cancer Center & Research Institute
Memphis, Tennessee

September
17
Tuesday
6:15 PM

EGFR-Mutant NSCLC

Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes

Chicago, Illinois

Kathryn Beal, MD
Radiation Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York

Sandip Patel, MD
Associate Professor, Department of Medicine
UC San Diego Health
Co-Leader, Experimental Therapeutics
Deputy Director, San Diego Center for Precision Immunotherapy
Assistant Director, Clinical Trials Office
UC San Diego Moores Cancer Center
La Jolla, California

September
17
Tuesday
6:15 PM

EGFR-Mutant NSCLC

Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes

Chicago, Illinois

Kathryn Beal, MD
Radiation Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York

Sandip Patel, MD
Associate Professor, Department of Medicine
UC San Diego Health
Co-Leader, Experimental Therapeutics
Deputy Director, San Diego Center for Precision Immunotherapy
Assistant Director, Clinical Trials Office
UC San Diego Moores Cancer Center
La Jolla, California

September
20
Friday
12:30 PM

HCC

MasterClass & Tumor Board
Composing Personalized HCC Treatment Strategies: Insights on Harmonizing Patient Care With a Multidisciplinary Ensemble

Chicago, Illinois

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
Weill Medical College at Cornell University
New York, New York

September
22
Sunday
6:30 AM

Renal Cell Carcinoma

The Urologic Nurse Meets the Challenge of Renal Cell Carcinoma: Insights on Patient Care in an Expanding Treatment Landscape

Lake Buena Vista, Florida

Julia Batten, APRN, MSN, MPH
Huntsman Cancer Institute
University of Utah
Salt Lake City, Utah

September
23
Monday
5:15 PM

Precision Immuno-Oncology

A Pan-Cancer, Pan-Biomarker Exploration of the Opportunities to Realize the Potential of Precision Immuno-Oncology: Are Pathology Professionals Ready for the Challenge?

Kissimmee, Florida

Lynette M. Sholl, MD
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts

September
25
Wednesday
11:00 AM

Asthma

Teaming Up to Overcome Challenges in Severe Asthma Management: The Role of Targeted Therapy in Personalized Care

Philadelphia, Pennsylvania

William J. Calhoun, MD, FACP, FCCP, FAAAAI, FACAAI
University of Texas Medical Branch
Galveston, Texas

Neil Skolnik, MD
Sidney Kimmel Medical College
Thomas Jefferson University
Abington Jefferson Health
Abington, Pennsylvania

September
30
Monday
12:00 PM

Oncologic Emergencies

Identification, Triage, and Management of Immune-Related Adverse Effects in Patients With Cancer Presenting to the Emergency Department: Practical Guidance for Emergency Nurses

Austin, Texas

Sorayah Bourenane, MSN, RN, CNL
Emergency Center (EC) and Clinical Decision Unit (CDU)
The University of Texas MD Anderson Cancer Center
Houston, Texas

Marianne Davies, DNP, ACNP, AOCNP
Yale School of Nursing
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut

October
22
Tuesday
5:30 AM

Chronic obstructive pulmonary disease (COPD)

Winning Strategies for Diagnosing and Managing Chronic Obstructive Pulmonary Disease

New Orleans, Louisiana

Fernando J. Martinez, MD, MS
Weill Cornell Medical College
New York-Presbyterian Hospital/
Weill Cornell Medical Center
New York, New York

MeiLan K. Han, MD, MS
University of Michigan
Ann Arbor, Michigan

October
22
Tuesday
11:00 AM
October
23
Wednesday
5:30 AM

Severe Asthma

Living With Severe Asthma: Understanding the Patient Experience to Guide Therapeutic Decision-Making

New Orleans, Louisiana

Nicola A. Hanania, MD, MS
Airways Clinical Research Center
Baylor College of Medicine
Ben Taub Hospital
Houston, Texas

Cedric "Jamie" Rutland, MD
Rutland Medical Group
Newport Beach, California

October
26
Saturday
6:00 PM

Emergency Medicine

Best Practices for Recognizing & Managing Immune-Related Adverse Events in the Emergency Department: Become Aware, Stay Alert, Change Your Practice, & Keep Patients With Cancer Safe

Denver, Colorado

Evan J. Lipson, MD
Bloomberg~Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine
Baltimore, Maryland

Andrew Stolbach, MD, MPH
Johns Hopkins Hospital
Johns Hopkins University School of Medicine
Baltimore, Maryland

October
29
Tuesday
6:00 AM

Hemophilia

Recognizing and Managing Hemophilia in the Emergency Department in an Era of Expanding Therapeutic Options: A Progress-in-Practice MasterClass and Practicum

Denver, Colorado

Sarah Luisa Melendez, MD
Orlando Health Arnold Palmer Hospital for Children
Orlando, Florida

Doris Quon, MD, PhD
Orthopaedic Hemophilia Treatment Center
Los Angeles, California

November
11
Monday
6:30 PM
November
13
Wednesday
12:30 PM

Rheumatology

Recognizing and Managing Progressive Fibrosing ILD in Patients With Connective Tissue Diseases: Examining the Potential Clinical Implications of Antifibrotic Therapy

Atlanta, Georgia

Lorinda Chung, MD, MS
Stanford University School of Medicine
Palo Alto, California

Kevin R. Flaherty, MD, MS
University of Michigan
Ann Arbor, Michigan

November
16
Saturday
10:33 AM

Renal Cell Carcinoma

How I Think, How I Treat: Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC

Miami, Florida

Toni K. Choueiri, MD
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

November
16
Saturday
18:30 PM

TGCT (Tenosynovial Giant Cell Tumor)

Putting Tenosynovial Giant Cell Tumor on Notice: Multidisciplinary Treatment and Implications of New Science

Tokyo, Japan

Robin L. Jones, MD
Royal Marsden Hospital and
Institute of Cancer Research
London, England, United Kingdom

November
17
Sunday
6:00 AM

Diabetes

Reducing Cardiovascular Risks in Patients With Type 2 Diabetes: Identifying Your Role on the Diabetes Management Team

Philadelphia, PA

Mikhail Kosiborod, MD, FACC, FAHA
Saint Luke’s Health System
Haverty Cardiometabolic Center of Excellence
Cardiometabolic Research Program, Saint Luke’s Mid America Heart Institute
University of Missouri
Kansas City, Missouri

November
21
Thursday
5:30 PM

Glioblastoma

Brainstorming Personalized Care Strategies in Glioblastoma - Rethinking and Refining Therapeutic Algorithms With Tumor Treating Fields and Novel Systemic Approaches

Phoenix, AZ

Steven Brem, MD
Penn Brain Tumor Center
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

December
6
Friday
7:00 AM

Lymphoma

'How I Think, How I Treat'
BTK Inhibitors as a Clinical Strategy in CLL, MCL, and Beyond: Therapeutic Selection, Sequencing, and Next Steps

Orlando, Florida

Andre H. Goy, MD
John Theurer Cancer Center
Regional Cancer Care Associates
Georgetown University
Seton Hall
Hackensack Meridian School of Medicine
Hackensack, New Jersey

December
6
Friday
7:00 AM

Lymphoma

Realizing the Promise of Novel Therapeutics in NHL: A MasterClass and Tumor Board on Clinical Decision-Making in FL, MCL, and DLBCL

Orlando, Florida

John P. Leonard, MD
Weill Cornell Medicine
New York, New York

December
9
Monday
10:45 AM

Anemia in Chronic Kidney Disease

Exploring Emerging Strategies in the Management of Anemia in Chronic Kidney Disease

Las Vegas, Nevada

Jay B. Wish, MD
Indiana University Health
Indianapolis, Indiana

December
10
Tuesday
7:30 PM

Breast cancer

On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum

San Antonio, Texas

Professor Peter Schmid, FRCP, MD, PhD
Centre for Experimental Cancer Medicine
Barts Cancer Institute, St Bartholomew’s Hospital
London, England, United Kingdom

January
23
Thursday
5:45 PM
January
23
Thursday
5:45 PM

HCC/Liver cancer

Developing a Therapeutic Game Plan for the Management of Hepatocellular Carcinoma: Expert Insights From the Patient CaseBook

San Francisco, California

Richard S. Finn, MD
David Geffen School of Medicine at UCLA
Los Angeles, California

January
23
Thursday
5:45 PM

Gastrointestinal Cancers

Evidence and Practicalities: Checkpoint Inhibition in Gastrointestinal Cancers - Translating Recent Advances in Gastric, Esophageal, and Colorectal Cancers

San Francisco, CA

Manish A. Shah, MD
Center for Advanced Digestive Care
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
New York, New York

January
24
Friday
5:30 AM

Inflammatory bowel disorder (IBD)

Transforming the Management of Inflammatory Bowel Disease: A Closer Look at the Role of JAK Inhibitors and the Patient’s Perspective in Achieving Therapeutic Goals

Austin, TX

David T. Rubin, MD
Digestive Diseases Center
University of Chicago Medicine
Chicago, Illinois

January
24
Friday
5:30 PM

Biliary Cancers

Blazing the Therapeutic Management Trail of Biliary Cancers: Get Prepared for a New Era of Molecular- and Mutation-Driven Treatments

San Francisco, CA

Milind Javle, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

February
13
Thursday
6:30 PM

Bladder cancer

Raising the Bar With Innovative Therapy for Bladder Cancer: Insights on Clinical Decision-Making in the New Era of Care

San Francisco, CA

Arjun Balar, MD
Laura and Isaac Perlmutter Cancer Center
NYU Langone Health
New York, New York

February
14
Friday
6:15 PM

Oncology

Mapping the Pathways to Better Patient Outcomes in Prostate Cancer: Personal Insights and Guidance from the Patient CaseBook

San Francisco, CA

William K. Oh, MD
The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York

February
19
Wednesday
12:00 PM

Veno-occlusive disease (VOD)

Following the Trail of Evidence in VOD Management: How Modern Risk Assessment, Diagnostic Principles, and Treatment Are Improving Care

Orlando, FL

Mitchell S. Cairo, MD
Children and Adolescent Cancer and Blood Diseases Center
Maria Fareri Children’s Hospital
Westchester Medical Center (WMC)
New York Medical College
Valhalla, New York

February
20
Thursday
6:30 AM

CAR T Cell Therapy

Taking the Leap With CAR T: Opportunities for Improving Care and Optimizing Cell Therapy in Hematologic Cancers

Orlando, Florida

Michael R. Bishop, MD
University of Chicago
Chicago, Illinois

February
20
Thursday
12:00 PM

Hematology-Oncology

Changing the Paradigm of CMV Management: New Science and More Choices for Challenging Cases in the HCT Setting

Orlando, Florida

Roy F. Chemaly, MD, MPH, FIDSA, FACP
The University of Texas MD Anderson Cancer Center
Houston, Texas

February
21
Friday
6:30 AM

Myeloproliferative Neoplasms

State-of-the-Art Solutions for Myelofibrosis: The Intersection of JAK Inhibitors, Allogeneic Transplant, and Other Strategies for Patient Care

Orlando, Florida

Prithviraj Bose, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas

Jeanne M. Palmer, MD
Mayo Clinic
Phoenix, Arizona

February
21
Friday
12:00 PM

Hematology-Oncology

Changing Perspectives on Multiple Myeloma and ASCT: Clinical Decision-Making, New Evidence, and Expanding Therapeutic Options

Orlando, Florida

Sagar Lonial, MD, FACP
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Philippe Moreau, MD
University Hospital of Nantes
Nantes, France

February
22
Saturday
12:00 PM

Acute Myeloid Leukemia

The Continuing Wave of Innovation in AML: Getting the Most From the Convergence of Novel Therapy and Allogeneic Transplant

Orlando, FL

Harry P. Erba, MD, PhD
Duke University Medical Center
Durham, North Carolina

James M. Foran, MD, FRCPC
Mayo Clinic Cancer Center
Mayo Clinic
Jacksonville, Florida

February
27
Thursday
5:15 PM

Head and Neck Cancer

Multimodal Head and Neck Cancer Care Meets the Immunotherapy Era: A Look at the Changing Nature of Multidisciplinary Collaboration and Integrated Treatment Strategies

Scottsdale, AZ

Barbara Burtness, MD
Yale University School of Medicine
Yale Cancer Center
New Haven, Connecticut

February
29
Saturday
12:20 PM

Multiple Sclerosis

Navigating the Evolving Management Paradigm Across Multiple Sclerosis Phenotypes in the Age of Potential Prognostic and Predictive Biomarkers

West Palm Beach, FL

Stephen Krieger, MD, FAAN
Mount Sinai Medical Center
Corinne Goldsmith Dickinson Center for MS
New York, New York

Clyde E. Markowitz, MD
Hospital of the University of Pennsylvania
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

March
02
Monday
6:00 AM

HER2 Testing/Treatment

Increasing Importance of HER2 and HER3 Testing in the Context of an Expanding Targeted Therapies Landscape for Breast, Gastrointestinal, Lung, and Other Cancers: Latest Updates and Practical Guidance for Pathologists

Los Angeles, California

Farnaz Dadmanesh, MD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California

Laura H. Tang, MD, PhD
Memorial Sloan-Kettering Cancer Center
New York, New York

March
3
Tuesday
6:00 AM

Leukemia

Precision Diagnostics and Modern Therapy in AML: Innovation and Insights for Pathologists on Personalized Medicine and Team-Based Care

Los Angeles, California

Carlos E. Bueso-Ramos, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Naval Daver, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

March
4
Wednesday
6:00 AM

Immuno-Oncology Biomarkers

Leveraging Biomarkers to Guide Candidate Selection for Cancer Immunotherapies: Precision is Paramount, Collaboration is Crucial

Los Angeles, California

Kurt Schalper, MD, PhD
Yale School of Medicine
Yale Cancer Center
New Haven, Connecticut

March
17
Tuesday
5:30 PM

ASMD

Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency

San Antonio, TX

Robin Lachmann, MD, PhD
National Hospital for Neurology and Neurosurgery
University College London Hospitals
London, United Kingdom

March
20
Friday
6:45 AM

PARP

Targeting Pathogenic Mutations in the DNA Damage Response Pathway: Genetic Testing and Counseling in the Era of Precision Medicine and Next-Generation Sequencing

San Antonio, TX

Bradley J. Monk, MD, FACS, FACOG
Arizona Oncology (US Oncology Network)
University of Arizona College of Medicine
Creighton University School of Medicine at St. Joseph's Hospital
US Oncology Research Network
Phoenix, Arizona

Mike Janicek, MD
Medical Director
Virginia G. Piper Cancer Genetic Risk Assessment Center
Arizona Oncology Genetics Program
President
Arizona Oncology (US Oncology Network)
Phoenix Division
Scottsdale, Arizona

March
27
Friday
5:30 PM
March
27
Friday
5:30 PM

Breast Cancer

Making the Most of the New Era of Immuno-Oncology in TNBC: Essential Guidance for Surgeons on How to Maximize the Potential of Immunotherapies and Combinations in Advanced and Early-Stage Breast Cancer

Boston, MA

Elizabeth A. Mittendorf, MD, PhD
Brigham and Women’s Hospital
Dana-Farber/Brigham and Women’s Cancer Center
Boston, Massachusetts

April
22
Wednesday
6:00 AM
May
2
Saturday
5:30 PM

Leukemia

Meeting the Many Challenges of AML: Oncology Nurse Tactics for a Complex Disease in an Era of Novel Therapies

San Antonio, TX

Sara M. Tinsley, PhD, APRN, AOCN
University of South Florida, College of Nursing
Moffitt Cancer Center
Tampa, Florida

April
3
Wed
7:30 AM

Phenylketonuria

Diminishing the Burden of Phenylketonuria During Adulthood: New Science & Encouraging Stories Highlighting the Critical Role of Adjunctive Therapy in Alleviating Neurocognitive Symptoms and Easing Dietary Constraints

Seattle, WA

Jerry Vockley, MD, PhD
University of Pittsburgh
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania

Stephanie Sacharow, MD, FACMG
Harvard Medical School
Boston Children’s Hospital
Boston, Massachusetts

May
3
Friday
5:30 PM

Bladder Cancer

Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care

Chicago, Illinois

Neal D. Shore, MD, FACS
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, South Carolina

May
4
Saturday
6:15 AM

Breast Cancer

On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum

Dallas, TX

Elizabeth A. Mittendorf, MD, PhD
Brigham and Women’s Hospital
Dana-Farber/Brigham and Women’s Cancer Center
Boston, Massachusetts

May
5
Sunday
6:00 PM
May
19
Sunday
6:30 PM

Pulmonology

Systemic Sclerosis–Associated Interstitial Lung Disease: Expert Insights on Early Diagnosis and Optimal Management

Dallas, Texas

Marilyn K. Glassberg, MD
University of Miami School of Medicine
Miami, Florida

May
30
Thursday
6:30 AM

Multiple Sclerosis

Personalizing Disease-Modifying Therapy for Multiple Sclerosis in the Era of Expanding Treatment Options and Potential Biomarkers

Seattle, Washington

Edward J. Fox, MD, PhD
MS Clinic of Central Texas
Central Texas Neurology Consultants
University of Texas Dell Medical School
Round Rock, Texas

May
31
Friday
6:30 PM

Head and Neck Cancer

Mapping Progress With Immune Checkpoint Inhibitors in Head and Neck Cancer: Expert Views on Immunotherapy as a Component of Multimodal Care

Chicago, Illinois

Ezra Cohen, MD, FRCPSC, FASCO
UC San Diego Health
San Diego Center for Precision Immunotherapy
UC San Diego Moores Cancer Center
La Jolla, California

May
31
Friday
6:30 PM

Pancreatic Cancer

Stories From The Pancreatic Cancer CaseBook: Taking the Road to Improved Outcomes With Modern Therapeutic Concepts and Innovative Treatments

Chicago, Illinois

Johanna C. Bendell, MD
Sarah Cannon Research Institute
Nashville, Tennessee

May
31
Friday
6:30 PM

Renal Cell Carcinoma

Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy

Chicago, Illinois

David F. McDermott, MD
Beth Israel Deaconess Medical Center
Dana-Farber Harvard Cancer Center Kidney Cancer Program
Harvard Medical School
Boston, Massachusetts

May
31
Friday
6:30 PM

Lymphoma

A MasterClass on Innovative Therapy in B-Cell Lymphoma: Evidence, Clinical Guidance, and Insights on the Future of Patient Care

Chicago, Illinois

Nathan H. Fowler, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas

May
31
Friday
6:30 PM

Myelofibrosis

MasterClass and Case Forum: Changing the Treatment Story in Myelofibrosis: New Science and More Choices for Challenging Cases in the JAK Inhibitor Era

Chicago, Illinois

Professor Claire Harrison
Guy's and St Thomas' NHS Foundation Trust
South London Genomics Medicine Centre
London, England, United Kingdom

June
1
Saturday
6:30 PM

Prostate Cancer

New Concepts in Prostate Cancer Care: What Oncologists Need to Know to Optimize Patient Outcomes

Chicago, Illinois

Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

June
1
Saturday
6:30 PM

Hepatocellular Carcinoma

“How I Think, How I Treat”—Embarking on a New Treatment Era in Hepatocellular Carcinoma: A Personal Take on Integrating Recent Evidence Into the Continuum of Care for Patients With HCC

Chicago, Illinois

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
Weill Medical College at Cornell University
New York, New York

June
1
Saturday
6:30 PM

Non—Small Cell Lung Cancer

Candid Conversations About NSCLC—Live From Chicago: Navigating Immunotherapies and Combinations in the Search for the Best Strategy for Each Patient

Chicago, Illinois

Benjamin Levy, MD
Johns Hopkins School of Medicine
Johns Hopkins Sidney Kimmel Cancer Center (SKCC) at Sibley Memorial Hospital
Washington, District of Columbia